NCT07573371Toboroz
Understanding and Tailored Treatment of Low Anterior Resection Syndrome
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. máj. 7.
Rövid összefoglaló (regiszter, angolul)
The goal of this observational study is to learn why some patients develop low anterior resection syndrome (LARS) after colorectal cancer treatment. The study also aims to identify different subtypes of LARS and understand which patients may respond to specific treatments. The main questions it aims to answer are: * What physiological and imaging changes are associated with LARS? * How do patients with LARS differ from patients without LARS after colorectal cancer surgery? * Are there measurable differences between LARS, patients treated with organ-preserving chemoradiotherapy, and patients with fecal incontinence? Participants will: * Complete advanced physiological and imaging assessments related to bowel function * Be compared with four control groups: * patients without LARS after colorectal cancer surgery * patients treated with organ-preserving chemoradiotherapy * patients with fecal incontinence and urge fecal incontinence * Take part in a single study visit where all measurements are performed
- Állapot (regiszter)
- Toboroz
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 145 (tervezett)
- Első benyújtás
- 2026. ápr. 20.
- Kezdés
- 2024. szept. 17.
- Elsődleges befejezés
- 2026. dec. 31.
- Fő szponzor
- Aalborg University Hospital
- Betegségek
- Vastagbélrák
- NCT-szám
- NCT07573371
Mit vállalsz
- Vizsgálat típusa: Megfigyeléses
- Tervezett résztvevők: 145
- 2024. szept. 17. és az elsődleges befejezés (2026. dec. 31.) között
- 3 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Participation in concomitant clinical trial
Más betegség
- Connective tissue disorders
- Parkinson's disease
- Allergic to latex
- Known intestinal obstruction, significant intestinal strictures or perforation. If in doubt about intestinal stricture, the patient will be examined with MRI of the small intestine, colonoscopy or other supplementing examination
- Disorders of swallowing
- History of anastomotic leakage following rectal resection and sphincter preserving therapy
- Evidens of local recurrence or dessimination of the cancer
Egyéb
- General exclusion criteria
- Persons that are not able to understand information
- Non-MRI compatible pacemaker, clips or other metal objects in the body. Patients implanted with a pacemaker for sacral nerve modulation will not undergo MRI postoperatively.
- Piercings that cannot be removed before MRI
- Claustrophobia
- Abdominal diameter equal or more than 140 cm
- Have other individual factors, in the opinion of the physician/healthcare professional, in which participating is contraindicated
- Pregnant women
- Specific exclusion criterias for LARS patients
Kiket keres a vizsgálat
- General:
- Must be able to read and understand Danish.
- All participants must be adults and >18 years and have full legal capacity.
- Assessed by study personnel to have understood the research protocol, being able to comply with investigation procedures as well as ability to come to the hospital at the agreed timepoints, and to complete the trial.
- Specific inclusion criteria for LARS patients:
- Patients operated for rectal cancer with a rectal resection and sphincter preserving surgery at a minimum of three months postop.
- If patients have received a temporary protective ileostomy, this should have been reversed for a minimum of three months postop.
- Specific inclusion criteria for fecal incontinence patients and urge fecal incontinence patients
- Patients planned for neuromodulation.
- Satisfactory interoperative test results leading to permanent implantation of a pacemaker for sacral nerve modulation.
- Specific inclusion criteria for "watch and wait" patients:
- Rectum/colon cancer patients treated with organ-preserving treatment, i.e., chemotherapy and radiotherapy with a complete clinical and radiological response at a minimum of 12 months posttreatment.
Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Helyszínek (3)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Aalborg University Hospital | Aalborg | Dánia | Fut, nem toboroz |
| Aarhus University Hospital | Aarhus | Dánia | Toboroz |
| Vejle Hospital | Vejle | Dánia | Toboroz |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.